Healthscope has retested the $2.07 price gap and has seen strong buying support.
We see HSO as a good long-term value play with improving earnings over the next 2 – 5 years.

Healthscope

Healthscope has retested the $2.07 price gap and has seen strong buying support.
We see HSO as a good long-term value play with improving earnings over the next 2 – 5 years.

Healthscope
Join Investor Signals today and start your journey to better, more disciplined returns.